2016
November
Public Domain by US National Institutes of Health
| A new gene therapy is under development for the treatment of cancer patients for whom currently no therapy options are available. Essentially cells are taken from the patient, genetically modified with an approach called CRISPR/Cas9 and then re-injected so that they can attack the cancer cells. Side effects and effectivity are currently studied. |